You Think The U.S. Has Vaccine Issues? 130 Countries Haven't Even Started Vaccinating
For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.
by Jason Beaubien
Feb 14, 2021
4 minutes
In some countries, citizens are grumbling about the inefficient rollout of COVID-19 vaccines. It's unclear exactly when doses will be available. Websites for appointments keep crashing. Lines are long.
And then there are the 130 countries that "are yet to administer a single dose," according to UNICEF. That's 2.5 billion people who so far have been completely shut out of the global vaccine campaign.
Many of these low- and middle-income countries are urgently shopping for vaccines. But with just a handful of pharmaceutical manufacturers having successfully come up with vaccines, doses are incredibly scarce.
Lack of supply isn't the only issue. Now there are questions about whether the
You’re reading a preview, subscribe to read more.
Start your free 30 days